Literature DB >> 3918946

Induction of HLA class-II antigen expression on human carcinoma cell lines by IFN-Gamma.

R Schwartz, F Momburg, G Moldenhauer, B Dörken, V Schirrmacher.   

Abstract

The effects of recombinant interferon gamma (IFN-gamma) on HLA antigen expression were examined in various human carcinoma cell lines: carcinomas of the lung (ChaGo, Oat 75, SK-LC-LL), colon (HT-29, WiDr), larynx (HEp-2), cervix (ME-180) and mammary gland (AlAb). Surface expression of HLA antigens was determined using monoclonal antibodies directed against monomorphic determinants of HLA class II (HD II, 2.06) and HLA class I (W6/32) by several techniques including indirect immunofluorescence, immunoperoxidase assay, radioimmunoassay of cells, and immunoprecipitation of radioiodinated cells. Without previous exposure to IFN-gamma, HLA class-II antigen was surface-expressed on a small subpopulation of HEp-2 only. All cell lines examined, except AlAb, could be induced to cell-surface expression of HLA class-II antigen after 48 hr incubation in the presence of IFN-gamma (10 units/ml). HLA class-I antigen was present on all cell lines even without treatment, and it was increased after IFN-exposure. Incorporation of 3H-thymidine and 3H-leucine and expression of the transferrin receptor were not significantly altered by IFN-gamma application, indicating a specific regulatory effect of IFN-gamma on HLA antigen expression. Our data demonstrate that HLA class-II surface expression is inducible by IFN-gamma in a variety of epithelial tumor lines. This may have implications for the host immune system defense mechanisms against tumors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3918946     DOI: 10.1002/ijc.2910350217

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  Differential growth inhibition and enhancement of major histocompatibility complex class I antigen expression by interferons in a small-cell lung cancer cell line and its doxorubicin-selected multidrug-resistant variant.

Authors:  S P Cole; B M Campigotto; J G Johnson; B E Elliott
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 2.  Rationale for immunotherapy of renal cell carcinoma.

Authors:  R Heicappell; R Ackermann
Journal:  Urol Res       Date:  1990

3.  Recombinant human interferon gamma exerts an anti-proliferative effect and modulates the expression of human leukocyte antigens A,B,C and DR in human urothelial cell lines.

Authors:  S S Ottesen; V Ahrenkiel; J Kieler
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 4.  Autologous graft-versus-host disease.

Authors:  M J Kennedy; A D Hess
Journal:  Med Oncol       Date:  1995-09       Impact factor: 3.064

5.  Establishment of Primary Cultures of Human Biliary Epithelium and Induction of Class II Major Histocompatibility Complex Antigens by Interferon Gamma.

Authors:  A J Demetris; B Markus; S Saidman; J Fung; L Makowka; R Duquesnoy; T E Starzl
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

6.  HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker.

Authors:  Giuseppe Sconocchia; Serenella Eppenberger-Castori; Inti Zlobec; Eva Karamitopoulou; Roberto Arriga; Andrea Coppola; Sara Caratelli; Giulio Cesare Spagnoli; Davide Lauro; Alessandro Lugli; Junyi Han; Giandomenica Iezzi; Cristina Ferrone; Amedeo Ferlosio; Luigi Tornillo; Raoul Droeser; Piero Rossi; Antonio Attanasio; Soldano Ferrone; Luigi Terracciano
Journal:  Neoplasia       Date:  2014-01       Impact factor: 5.715

7.  Class II (HLA-DR, -DP, and -DO) antigens on intestinal epithelia in ulcerative colitis, Crohn's disease, colorectal cancer and normal small intestine.

Authors:  Y Horie; M Chiba; M Iizuka; O Masamune
Journal:  Gastroenterol Jpn       Date:  1990-10

8.  Effect of gliadin and other food peptides on expression of MHC class II molecules by HT-29 cells.

Authors:  T Mothes; U Bendix; C Pfannschmidt; I Lehmann
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

Review 9.  Autologous graft-versus-host disease: immunotherapy of breast cancer after bone marrow transplantation.

Authors:  M J Kennedy; R J Jones
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  Interferon-beta can induce the production of plasminogen activator by cultured human cancer cells.

Authors:  M Karai; M Namba
Journal:  Experientia       Date:  1987-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.